Electrical Stimulation Improves Exercise Tolerance in Patients With Advanced Heart Failure on Continuous Dobutamine Use
- Conditions
- Heart FailureVentricular Dysfunction, Left
- Interventions
- Other: Physical Therapy SessionDevice: Neuromuscular Electrical Stimulator
- Registration Number
- NCT02668419
- Lead Sponsor
- Federal University of São Paulo
- Brief Summary
The purpose of this study is to determine whether neuromuscular electrical stimulation can improve exercise tolerance for patients with heart failure and continuous dobutamine use in a hospital.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 49
- Advanced heart failure (Stage D - Left ventricle ejection fraction <30%)
- New York Heart Association class III-IV
- Standard medical therapy for heart failure management
- Continuous inotropic infusion
- Unstable angina pectoris
- Recent (6 months) acute coronary syndrome
- Arrythmias
- Chronic renal failure
- Diabetes Mellitus
- Peripheral vascular diseases
- Inability to walk
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Usual Care Physical Therapy Session Patients in this group were subject to regular Physical Therapy Sessions in the hospital and each session consisted of breathing exercises and global active exercises of the upper and lower limbs in bed. The treatment was applied twice a day during the hospitalization period. The protocol was interrupted if the patient had signs or symptoms suggestive of poor tolerance to exercise. Neuromuscular Electrical Stimulator Neuromuscular Electrical Stimulator Lower limb muscles of both legs were simultaneously stimulated using self adhesive surface rectangular electrodes. During all session period, the patients were maintained in the supine Fowler 45º position. The stimulation intensity was progressively increased according to the patient tolerance until a muscular contraction was observed. Stimulation was performed twice a day; the session duration was 60 min. Heart rate, blood pressure, respiratory rate and pulse oximetry were monitored throughout the sessions, in all patients.
- Primary Outcome Measures
Name Time Method Functional capacity evaluated using the 6-minute walk test (6MWT) Change from assessment at admission and at patient discharge Functional capacity was evaluated using the 6-minute walk test (6MWT), by a single evaluator blinded to the group allotment, in accordance with American Thoracic Society criteria.
- Secondary Outcome Measures
Name Time Method Change in the intravenous inotropic support dosage Change from the first day of the protocol and patient discharge For all patients, the inotropic intravenous dose was adjusted daily by a single clinician (prescriber) blinded to the group allocation. Weaning from inotropic support was performed by the prescriber based on the improvement of clinical signs (level of consciousness, peripheral perfusion and blood pressure).
Trial Locations
- Locations (1)
Federal University of Sao Paulo
🇧🇷Sao Paulo, Brazil